Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - COMMON STOCK
Common Stock CRVS - Corvus Pharmaceuticals, Inc.
5 K
LAST VALUE
0.00%
2 YEAR CAGR
10.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR